The Medicines Patent Pool, which negotiates licenses with the manufacturers of new drugs that allow other companies to produce generic versions for distribution in low- and middle-income countries, is looking to expand beyond HIV drugs to medications...
While almost 60% of people living with HIV globally are on treatment, the numbers for new seroconversions averted and HIV-related deaths are no longer improving.
In a recent survey of people not living with HIV, many still believed that people living with HIV should not be allowed to work in hospitals, restaurants, or universities, among other occupations, and 68% said they would be uncomfortable dating someo...
HIV Prevention and Treatment Strategies for Africa's Growing Teen and Young Adults Are Central to Future World Progress
For the world's HIV epidemics to be controlled, effective community-based prevention programs reaching adolescents and young people, especially in sub-Saharan Africa, need to be developed, funded, and scaled up.
Barr, a longtime AIDS activist and co-founder of Treatment Action Group (TAG), was the coordinator for the Joep Lange Institute's AIDS 2018 preconference workshop, Meeting the 90-90-90 Targets: Faster and Better.
Once viable long-acting HIV prevention and treatment options have reached the market, what will be their true impact? Leading HIV clinician-researcher Anton Pozniak, M.D., shares his expertise.